220364-34-1

Basic information

• Product Name: N-[3-(Bromomethyl)benzyl]carbamic acid tert-butyl ester
• Synonyms: [3-(Bromomethyl)benzyl]carbamic acid tert-butyl ester;N-[3-(Bromomethyl)benzyl]carbamic acid tert-butyl ester;tert-Butyl 3-(broMoMethyl)benzylcarbaMate;3-(Boc-aMinoMethyl)benzylbroMide;tert-Butyl 3-(bromomethyl)
• CAS NO: 220364-34-1
• Molecular Formula: C₁₃H₁₈BrNO₂
• Molecular Weight: 300.2
• Mol File: 220364-34-1.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Density: 1.304
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: N-[3-(Bromomethyl)benzyl]carbamic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: N-[3-(Bromomethyl)benzyl]carbamic acid tert-butyl ester(220364-34-1)
• EPA Substance Registry System: N-[3-(Bromomethyl)benzyl]carbamic acid tert-butyl ester(220364-34-1)

Safety Data

• Hazardous Substances Data: 220364-34-1(Hazardous Substances Data)

Usage

General Description

N-[3-(Bromomethyl)benzyl]carbamic acid tert-butyl ester is a chemical compound with the molecular formula C13H17BrNO2. It is a carbamic acid tert-butyl ester derivative that contains a benzyl group with a bromomethyl substituent. N-[3-(Bromomethyl)benzyl]carbamic acid tert-butyl ester is commonly used in organic synthesis and chemical research as a reagent or intermediate for the synthesis of various pharmaceuticals and agrochemicals. It is important to handle this compound with caution as it may pose certain health hazards and reactivity risks.

Upstream product

• 226070-69-5 1,1-dimethylethyl {[3-(hydroxymethyl)phenyl]methyl}carbamate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 34231-22-6 [3-(aminomethyl)phenyl]methanol 
• 874-97-5 3-(hydroxymethyl)benzonitrile 
• 28188-41-2 m-(bromomethyl)benzonitrile 
• 391957-11-2 3-(tert-butyldimethylsilyloxymethyl)benzylamine 
• 24964-64-5 3-Cyanobenzaldehyde 

Downstream Products

• 586373-50-4 {3-[3-bromo-4-(4-fluorobenzyloxy)-2-oxo-2H-pyridin-1-ylmethyl]benzyl}carbamic acid tert-butyl ester 
• 499789-60-5 isopropyl 2-[(3-{[(t-butoxycarbonyl)amino]methyl}-phenyl)-methyl]-2,5-dihydrotetrahydro-2-furancarboxylate 

Relevant articles and documents

Reactive Oxygen Species-Sensitive Nitric Oxide Synthase Inhibitors for the Treatment of Ischemic Stroke

Disclosed are ROS-sensitive NOS inhibitors, as well as methods of making and using the same.

Multicyclic bis-amide MMP inhibitors

The present invention relates generally to bis-amide group containing pharmaceutical agents, and in particular, to multicyclic bis-amide MMP-13 inhibitor compounds. More particularly, the present invention provides a new class of MMP-13 inhibiting compounds, containing a pyrimidinyl bis-amide group in combination with a heterocyclic moiety, that exhibit an increased potency and solubility in relation to currently known bis-amide group containing MMP-13 inhibitors.

CYCLIC COMPOUND AND PPAR AGONIST

The present invention provides a novel compound having an excellent PPAR agonist action. More specifically, it provides a compound represented by the following formula, a salt thereof, an ester thereof or a hydrate of them. Wherein a, b and c are the same as or different from one another and each represents 0 to 4; R1 to R6 are the same as or different from one another and each represents a hydrogen atom, a hydroxyl group, a cyano group, a halogen atom, etc.; A1 and A2 are the same as or different from each other and each represents a single bond, an oxygen atom, etc.; L, M and T each represent a single bond, an alkylene group having one to six carbon atoms, etc.; W represents a carboxyl group; the partial structure represented by the formula:------ represents a single bond or a double bond; X represents a single bond, an oxygen atom, -NRX1CQ1O-, etc.; Y represents Y1-Y2- (wherein Y1 represents a 5 to 14-membered aromatic ring having one to four substituents, etc.; and Y2 represents a single bond or a 5 to 14-membered aromatic ring); and the ring Z represents a 5 to 14-membered aromatic ring which have one to four substituents selected form the above-mentioned Group A, may have one or more hetero atoms and may be partially saturated.